ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Cash Flow
NASDAQ:ADPT - Nasdaq - US00650F1093 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -141.89M | -159.59M | -225.30M | -200.40M | -207.30M | |||
| Depreciation Amortization | 18.77M | 19.26M | 22.23M | 20.90M | 14.00M | |||
| Change In Working Capital | -23.29M | -17.45M | -46.18M | -71.50M | -56.80M | |||
| Interest Paid | 8.95M | 8.86M | 8.98M | N/A | N/A | |||
| Other non cash items | 61.07M | 62.58M | 92.93M | 67.00M | 57.40M | |||
| OPERATING CASH FLOW | -85.34M | -95.21M | -156.32M | -183.90M | -192.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.41M | -3.66M | -10.70M | -16.30M | -61.70M | |||
| Other Investing Activity | 62.27M | 81.46M | 140.34M | 19.30M | 243.00M | |||
| INVESTING CASH FLOW | 58.86M | 77.79M | 129.65M | 2.90M | 181.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 5.65M | 241.00K | 2.25M | 7.90M | 26.70M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 124.40M | 400.00K | |||
| FINANCING CASH FLOW | 5.65M | 241.00K | 2.25M | 132.30M | 27.10M | |||
| CHANGE IN CASH | -20.84M | -17.18M | -24.43M | -48.70M | 15.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -85.34M | -95.21M | -156.32M | -183.90M | -192.70M | |||
| Capital Expenditure | -3.41M | -3.66M | -10.70M | -16.30M | -61.70M | |||
| FREE CASH FLOW | -88.75M | -98.88M | -167.02M | -200.20M | -254.40M | |||
All data in USD